8-KEarnings & ResultsExhibits & Filings

Medtronic plc 8-K Report, Financial Results (Feb 18, 2025)

Filed February 18, 2025For Securities:MDT

Summary

Medtronic plc (MDT) has filed a Form 8-K with the SEC on February 18, 2025, to report its third quarter fiscal year 2025 financial results. The filing primarily serves to furnish the press release containing these results, which was issued on the same date. Investors should refer to the press release, provided as Exhibit 99.1, for detailed financial performance data, including revenue, earnings, and any forward-looking guidance or commentary provided by the company. While the 8-K itself is a brief procedural filing, the associated press release will contain the critical operational and financial metrics that investors will use to assess Medtronic's performance against expectations and to make informed investment decisions. Key areas to scrutinize in the press release will include segment performance, growth drivers, profitability trends, and management's outlook for the remainder of fiscal year 2025 and beyond.

Key Highlights

  • 1Medtronic plc (MDT) announced its third quarter fiscal year 2025 financial results on February 18, 2025.
  • 2The company filed a Form 8-K with the SEC to furnish its earnings press release.
  • 3The press release, dated February 18, 2025, is attached as Exhibit 99.1 to the filing.
  • 4Investors need to review the furnished press release for detailed financial performance and operational updates.
  • 5The filing is procedural, with the substantive financial information contained within the press release.
  • 6Key metrics such as revenue, earnings, and segment performance are expected to be detailed in the press release.

Frequently Asked Questions

The main purpose of this Form 8-K filing by Medtronic plc is to officially report its financial results for the third quarter of fiscal year 2025. It serves as a formal mechanism to submit the press release containing these results to the Securities and Exchange Commission (SEC).

The detailed financial results, performance analysis, and any management commentary are located in the press release dated February 18, 2025, which is furnished as Exhibit 99.1 to this 8-K filing. Investors should consult this press release for comprehensive information.

This report covers Medtronic's financial results for the third quarter of its fiscal year 2025.

The 8-K filing itself is primarily a procedural document for reporting financial results. Any significant new operational or strategic disclosures would be detailed within the accompanying press release (Exhibit 99.1), which investors should carefully review.